Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Comparative Effects of Janda and IASTM on UCS

NCT07372391
completednot_applicable

Effects of IASTM in the Treatment of Adhesive Capsulitis

NCT05358730
completednot_applicable

Effects Of Instrument Assisted Soft Tissue Mobilization on Pain, Grip Strength and Functional Activity in Patients With Lateral Epicondylitis

NCT05698108

Clinical Trials (3)

Showing 3 of 3 trials
NCT07372391Not Applicable

Comparative Effects of Janda and IASTM on UCS

Completed
NCT05358730Not Applicable

Effects of IASTM in the Treatment of Adhesive Capsulitis

Completed
NCT05698108Not Applicable

Effects Of Instrument Assisted Soft Tissue Mobilization on Pain, Grip Strength and Functional Activity in Patients With Lateral Epicondylitis

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3